Researchers developed a molecule that targets bacterial cells by two different mechanisms--attacking the cell membrane and disabling folate synthesis. This molecule seems to prevent bacteria from developing antibiotic-resistance.
Current polio vaccines have been successful in nearly eradicating polio in the world. Unfortunately, there have been emerging cases of polio in recent years. To combat this, scientists have designed a new oral poliovirus vaccine that could result in a…
CIFAR Fellows’s paper questions whether diabetes, heart attacks and strokes are actually non-communicable diseases (NCDs). Microbiota (bacteria, viruses, fungi) that spread flu, HIV/AIDS, may also carry NCDs. People with NCDs have damaged microbiota,…
Scientists have developed a biodegradable ultrasound speaker that can be placed inside the brain. When activated, it makes the blood-brain barrier permeable, potentially allowing certain drugs such as brain cancer chemotherapy and antidepressants to…
Flu shots have an exciting new role in the world of cancer therapy! A recent study shows that flu vaccines could be used to boost the effects of cancer immunotherapy.
A new migraine medication called ubrogepant recently passed a large scale phase 3 clinical trial. This medication may be able to help treat patients that cannot tolerate or do not respond to the most common types of migraine medication.
by Isabella Grabski
figures by Jovana Andrejevic
Clinical trials are critical to study the safety and effectiveness of new drugs, but they are no small endeavor. The cost of a clinical trial can range anywhere from $7 million to over $50 million, and…